-
This news sheet is aimed at healthcare professionals and highlights problems with wearers of nicotine or other drug patches during MRI scans, blood glucose meters, power cables and endotracheal tubes.
-
The June issue of ‘Drug Safety Update’ includes: drug safety advice for antipsychotics (risk of venous thromboembolic events), Chloral hydrate and Triclofos (not first-line options for insomnia), and for topical ketoprofen (reminder on risk of photosensitivity reactions); a Hot topic article on a pharmacy-based public awareness campaign about counterfeit medicines; and Stop press information about a possible interaction between clopidogrel and proton pump inhibitors.
-
This news sheet is aimed at healthcare professionals and highlights important safety issues and offers advice to ensure adequate knowledge of oxygen cylinder capacities to safely undertake in-hospital transfers.
-
This news sheet is aimed at healthcare professionals and is looking at the role of the Medical Device Liaison Officer within NHS trusts.
-
The May issue of ‘Drug Safety Update’ includes drug safety advice for antihypertensive medicines, and a Hot topic article outlining key safety information to support pharmacy availability of orlistat for weight loss.
-
The April issue of ‘Drug Safety Update’ includes drug safety advice for antiepileptics (adverse effects on bone), and a Hot topic article on responsibilities when prescribing a medicine off-label or when using an unlicensed medicine.
-
This document provides an overview of medical device related adverse incident reports received by the MHRA in 2008.
-
This news sheet is aimed at healthcare professionals and highlights problems with the use of medical devices. This issue covers topics including implantable drug pumps, non-invasive ventilators, female urinary catheters, intravenous catheters, fluoroscopy units and maintenance of devices.
-
The March issue of ‘Drug Safety Update’ includes drug safety advice for: the ADHD medicines methylphenidate and atomoxetine; the diabetes medicine exenatide (Byetta, risk of severe pancreatitis and renal failure); and for bisphosphonates (risk of atypical stress fracture with long-term alendronic acid treatment).
-
This Device Bulletin provides guidance on the MHRA's voluntary adverse incident reporting system, encourages users to report adverse incidents involving medical devices and provides information on the dissemination of Medical Device Alerts.